Shiff Susan Ph.D. - Insider Non-Derivative Transactions at Cara Therapeutics, Inc. (CARA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 4, 2024, Shiff Susan Ph.D.'s relationship to Cara Therapeutics, Inc. (CARA) is Director, and currently has 202,085 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CARA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Shiff Susan Ph.D. - Insider Non-Derivative Transactions of CARA Common Stock

Shiff Susan Ph.D. - Insider Non-Derivative Transactions at CARA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 5, 2024	Acquisition -- (Common Stock)	150647	0	202085
Jun 2, 2023	Acquisition -- (Common Stock)	32362	0	51438